Increasing Demand for Medical Marijuana to Fuel Revenue Growth Through 2028

As per study of Research Dive, medical marijuana (cannabis) market forecast revenue of $33,211.7 million in the year 2026 growing at CAGR of 27.4%.

Marijuana is more safe and has less severe side effects over other treatment options such as opioid-based treatments. It is more efficient in reducing nausea and also improving appetite among chemotherapy patients. Increasing cancer burden along with rising demand for chronic pain management & treatment is projected to drive the medical marijuana market growth. For instance, as per publication of the World Health Organization (WHO), in 2018, Cancer disease is the second leading cause of death cases, in which Lung, breast, prostate, liver, stomach and colorectal cancer are the common types of cancerous diseases. Moreover, R&D activities, Clinical trials along with commercialization of cannabis are anticipated to boost the global medical marijuana industry. However, stringent government regulation, lack of awareness in the emerging countries and absence of proper information shall restrain the medical marijuana market growth. China has the significant opportunities for the medical marijuana market; this is majorly due to China is primarily involved in the research and also it has heavy production of marijuana. Moreover, key players such as Hanma Investment Group received permission to extract CBD (Cannabidiol) in China. Currently this company exports 90% of its production, to the countries such as, Germany, the U.K., and the US.

Access to Exclusive PDF Sample Report Here! @ https://www.researchdive.com/download-sample/59

Pain management segment shall generate revenue of $13,882.5 million in 2026, increasing at a CAGR 27.0%. Pain management segment is broadly classified into neuropathic pain, cancer pain, and others. Rising prevalence of cancerous diseases attributed to primarily increase the necessity of pain management across the globe is anticipated to foster the global market.

Inhalation segment shall generate revenue of $23,082.2 million by the end of 2026, at a CAGR of 26.8% till 2026.This segment has enormous opportunities due to properties such as reduction in noxious emissions and quick effects. Topical segment shall generate revenue of $7,306.6 million by the end of 2026, at a CAGR of 28.9% till 2026.

Online segment will see enormous growth owing to, easy accessibility and significant changes in the legality of marijuana attributed to increasing need of E-commerce payment system in cannabis market will generate revenue of $8,767.9 million by the end of 2026, rising at a CAGR 31.0%. Dispensaries segment is expected to generate revenue of $24,443.8 million by the end of 2026, growing at a CAGR of 26.3%.

North America medical marijuana market size will cross $10,627.8 million in 2026, increasing at a CAGR 25.6%. North America marijuana market is anticipated to increase at fast rate owing to legalization of medical marijuana in Canada, in addition, extensive growth in cannabis based products for medicinal use and legalization of cannabis by the House Judiciary Committee in the US is expected boost the market in this regions.

Medical Marijuana market share for Asia-Pacific region is projected to grow at a CAGR of 29.5% by generating a revenue of $7,373.0 by 2026. Asia Pacific region is projected to witness significant growth owing to the piecemeal legalization of medicinal cannabis in the nations such as Australia and Israel. Additionally, Thailand is the nation that has fully legalized medicinal marijuana with multiple clinical applications.

Speak to our Expertise before buying Report@ https://www.researchdive.com/connect-to-analyst/59

Some of the significant medical marijuana market players are:

mCig
Emerald Health Therapeutics
ABcann Medicinals, Inc.
Insys Therapeutics, Inc.
Aphria, Inc.
Cannabis Sativa Inc.
Canopy Growth Corporation
GW Pharmaceuticals
Green Relief Inc.
Aurora Cannabis, Inc.

These players are initiating various steps in order strengthen their presence such as merger & acquisitions, new product development. For example, to meet the demand of rising number of patients, Green Relief Inc., a licensed manufacturer of marijuana based therapeutic medicines, has officially acquired a new facility department in Canada.

Covaxin vs Covishield: A Comparison between the Covid-19 Vaccines of India

The second wave of Covid-19 pandemic has reminded people the hard times faced during the coronavirus outbreak in 2020 in India. However, there is still an upper hand in 2021 in the fight against Covid-19, and this can be attributed to the nationwide vaccination drive. It has been clear that getting vaccinated is one of the simple yet effective ways to combat the pandemic. Vaccination helps in producing antibodies and boosts the immune system to fight against any infection. Besides, getting Covid-19 vaccination is known to reduce the severity of the infection and helps in lowering the chances of getting hospitalized due to the severe infection caused due to Covid-19. Covaxin Vs Covishield Currently, the Indian Government has approved two vaccines namely Covaxin and Covishield to fight Covid-19. Many people are wondering which vaccine is better among the two, and here is a quick read to help them answer all their queries. Covaxin Covaxin was given approval for by the Indian

Contactless Payment Market size share growth analysis market demand

Contactless payment, also called as a tap-and-go system is a secure mode where the transactions are done using technologies such as NFC (near field communication), RFID (radio frequency identification), infrared, and bluetooth. Contactless payment is hassle-free and convenient for customers as it takes only one-tenth of the time taken by the old-style electronic transaction.Contactless payment is becoming popular owing to its benefits such as secure and fast payments without any need for cash or identifying details. Initially, these type of payments or cards were used for the purpose oftravelling tickets only. But today, this technology has evolved and is helping customers to make payments for almost anything. However, the permissible amount for a contactless payment varies by country and by the bank. Access to PDF Sample Report Here! @ https://www.researchdive.com/download-sample/181 Recent Developments in the Contactless Payment Industry As per a Research Dive blog, the digital e

Development: Aerospace 3D Printing Market Strategy Planning by Top Manufacturers

Aerospace 3D Printing Market Analysis 2026: According to a study of the Research Dive, aerospace 3D printing market forecast shall cross $5,933.4 million by 2026 , growing at a CAGR of 26.8% during forecast period. Aerospace 3D printing is primarily used to increase the efficiency of A&D supply chain, reduction of storage costs of inventory and waste production materials. Furthermore, the Aerospace 3D printing industry is focusing more on creating parts of aircraft that are lighter and stronger than parts made by using traditional manufacturing. Astonishing advantages of 3D printings in the supply chain of the aerospace and defense industry are projected to surge in the global market. In addition, the financial support provided by the government and non-government organizations across the globe is also driving the 3D printing in aerospace industry. For instance, National Aerospace Technology Exploitation Programme grants £140,000 funds for UK based company Sigma Components

Industrial Research World

Search This Blog